CN Patent

CN1993320A — 作为11－β－羟基类固醇脱氢酶－1的抑制剂的磺酰化合物

Assigned to Merck and Co Inc · Expires 2007-07-04 · 19y expired

What this patent protects

结构式I的磺酰衍生物是11－β－羟基类固醇脱氢酶I型的选择性抑制剂。该化合物可用于治疗糖尿病，例如，非胰岛素依赖型糖尿病(NIDDM)、高血糖、肥胖症、抗胰岛素、血脂紊乱、高血脂、高血压、代谢综合征或综合征X，以及其它与NIDDM相联系的症状。

USPTO Abstract

结构式I的磺酰衍生物是11－β－羟基类固醇脱氢酶I型的选择性抑制剂。该化合物可用于治疗糖尿病，例如，非胰岛素依赖型糖尿病(NIDDM)、高血糖、肥胖症、抗胰岛素、血脂紊乱、高血脂、高血压、代谢综合征或综合征X，以及其它与NIDDM相联系的症状。

Drugs covered by this patent

Patent Metadata

Patent number
CN1993320A
Jurisdiction
CN
Classification
—
Expires
2007-07-04
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.